My Account

News

ASPC member featured in Wall Street Journal Debate on Cholesterol Drugs
Click here to read ASPC member Dr. Roger S. Blumenthal's contribution to the Wall Street Journal Debate, Should Healthy People Take Cholesterol Drugs to Prevent Heart Disease?, which was published in the January 23, 2012, edition of the Wall Street Journal.


ASPC Debates Now Published
Clinical Cardiology has published a series of debate articles by ASPC members Nathan D. Wong PhD, MPH, Nanette K. Wenger MD, and Ezra A. Amsterdam MD.

The Annual ASPC debate, Coronary Heart Disease in Men and Women - Does One Size Fit All?, includes the following articles:

  • Wong, N. D. (2011). "American Society for Preventive Cardiology Annual Debate: Coronary Heart Disease in Men and Women-Does One Size Fit All?" Clinical Cardiology 34(11): 653-653.
  • Amsterdam, E. A. (2011). "Primary Prevention of Coronary Heart Disease in Men and Women: Does 1 Size Fit All? Yes!" Clinical Cardiology 34(11): 658-662.
  • Wenger, N. K. (2011). "Coronary Heart Disease in Men and Women: Does 1 Size Fit All? No!" Clinical Cardiology 34(11): 663-667.

To read the Annual ASPC debates, please visit Clinical Cardiology Online.


22nd Great Wall International Congress of Cardiology
ASPC was honored with an Award of International Collaboration at the 22nd Great Wall International Congress of Cardiology (GW-ICC) and Asia Pacific Heart Federation Scientific Congress 2011, which was held October 13-16, 2011 in Beijing, China. Nathan Wong, PhD, and Ezra Amsterdam, MD, attended the GW-ICC, conducted a Joint Session between ASPC and the Chinese Society of Cardiology, and accepted the Award of International Collaboration on behalf of ASPC.

Award Award of International Collaboration - pictured from the left Nathan D. Wong, PhD, President, ASPC, Dayi Hu, MD, President, Chinese Society of Cardiology and Great Wall International Congress of Cardiology, and Ezra Amsterda, MD, Chair, Publications Committee, ASPC.

Award Nathan D. Wong, PhD and Ezra Amsterdam, MD at Joint Session of ASPC and Chinese Society of Cardiology.





Dr. Wong Honored by the International Academy of Cardiology

ASPC President, Nathan Wong, PhD was awarded the Jan J. Kellerman Memorial Award for distinguished work in the field of Cardiovascular Disease Prevention at 16th World Congress on Heart Disease held in Vancouver, BC, Canada. To read the complete article click here


Annual Meeting Events 2011


from left to right is Peter Wilson, MD, Elizabeth Barrett-Connor, MD, William B. Kannel, MD, and Donald Lloyd-Jones, MD.

The ASPC membership convened on March 25, 2011 in Atlanta, Georgia at the Marriott Marquis Hotel and Conference Center for the association's Annual Meeting, customarily held in conjunction with the American Heart Association's Council on Epidemiology & Prevention Annual Scientific Sessions.

Darwin Labarthe, MD, MPH, PhD, FAHA, Director of the Division for Heart Disease and Stroke Prevention (DHDSP) at the National Center for Chronic Heart Disease Prevention and Health Promotion, gave a presentation entitled From CVD to CVH: The Quiet Revolution on the shift from focusing on disease to concentrating on health.

On behalf of the ASPC Board of Directors, Nathan D. Wong, PhD, MPH, ASPC President, presented the ASPC's Joseph Stokes III Award for excellence and lifetime achievements in the field of preventive cardiology to William B. Kannel, MD, MPH, Senior Investigator on the Framingham Heart Study and Professor Emeritus, Boston University School of Medicine.

In addition to the Annual Meeting events, the ASPC President, Nathan D. Wong, PhD, MPH, mediated the Controversies in Preventive Cardiology debate. This year's topic was Prevention of Coronary Heart Disease in Women: Are the Similarities Greater than the Differences? Arguments were presented by ASPC board member Ezra Amsterdam MD, FACC and Nanette Wenger, MD, FACC. A transcript of the debate is being considered for inclusion in the ASPC's journal, Clinical Cardiology.


CardioSmart Launches the Hypertension Management Program Pilot in California

cardio

In an effort to help patients achieve better outcomes, the American College of Cardiology Foundation (ACCF) has developed the CardioSmart Hypertension Management Program. Currently in its pilot phase, the ACCF is reaching out to cardiovascular care professionals in California to recruit patients to participate.

The program features a free, interactive resource on CardioSmart.org which includes:

  • Educational modules
  • Blood pressure tracking/management tool
  • Support information

Each feature was designed and developed by hypertension experts. The CardioSmart Hypertension Management Program will allow you to more actively engage your patients in their own health management and help them succeed in attaining their blood pressure goals. The ACCF believes that with your help and commitment to this pilot, the CardioSmart initiative will make a real difference in your patients' outcomes and quality of life.

What the CardioSmart Hypertension Management Program Offers
The pilot is designed to help patients diagnosed with hypertension attain blood pressure levels recommended by the JNC-7 guidelines. The program will:

  • Clearly identify each patient's goals for target blood pressure
  • Educate them about the risks associated with high blood pressure and how levels can be decreased through lifestyle changes and medication adherence
  • Explain how to self-monitor and record blood pressure readings
  • Describe how to work with a healthcare provider in managing the condition
  • Provide incentives for ongoing participation

Getting Started
Please go to www.CardioSmart.org to register and commit to encouraging your patients to participate in the program. Once your registration is received, you be sent a welcome kit form the ACCF, which includes information to distribute to your patients about the CardioSmart Hypertension Management Program.

Questions?
Contact the ACCF at 202-375-6188 or via email at cardiosmartcalifornia@acc.org


Joint Session with the Chinese Society of Cardiology


From left to right are Yangfeng Wu, MD, Peter Wilson, MD, Dong Zhao, MD, Markus Perola, MD, and Nathan Wong, PhD.

On June 19, ASPC participated in a joint session with the Chinese Society of Cardiology. The session entitled "Optimizing Assessment of Cardiovascular Risk: What Does the Future Hold?" was presented at the World Congress of Cardiology held in Beijing was chaired by Nathan Wong, PhD and Dong Zhao, MD.